Search Results

Showing results 1301 - 1310 for leonard

Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. | Pathology & Laboratory Medicine

... 2006 Authors Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M, Hempstead B, Leonard JP...

https://pathology.weill.cornell.edu/research/publications/magnitude-stromal-hemangiogenesis-correlates-histologic-subtype-non-hodgkins

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. | Pathology & Laboratory Medicine

... FY, Chadburn A, Barrientos JC, Leonard JP, Ye F, Zhang D, Knowles DM, Wang YL Journal Leukemia...

https://pathology.weill.cornell.edu/research/publications/tyrosine-kinase-inhibition-diffuse-large-b-cell-lymphoma-molecular-basis

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies. | Pathology & Laboratory Medicine

..., Leonard JP Journal Ann Oncol Volume 19 Issue 7 Pagination 1327-1330 Date Published 2008 Jul ISSN 1569...

https://pathology.weill.cornell.edu/research/publications/intensive-treatment-strategies-may-not-provide-superior-outcomes-mantle-cell

Tailored organoid may help unravel immune response mystery | Sandra and Edward Meyer Cancer Center

... strategies for treating progressive indolent B-Cell NHL Leonard reflects on progress for lymphoma patients ...

https://meyercancer.weill.cornell.edu/news/2017-01-05/tailored-organoid-may-help-unravel-immune-response-mystery

Innovative immunotherapy more effective in treating an aggressive lymphoma than chemotherapy | Sandra and Edward Meyer Cancer Center

... for treating progressive indolent B-Cell NHL Leonard reflects on progress for lymphoma patients ...

https://meyercancer.weill.cornell.edu/news/2016-06-06/innovative-immunotherapy-more-effective-treating-aggressive-lymphoma-chemotherapy

Faculty Meeting

... McMillan, MHA Chief Administrative Officer John Leonard, MD Interim Chair, Weill Department...

https://medicine.weill.cornell.edu/sites/default/files/2022-state-of-wdom.pdf

Donor Spotlight: Supporting a Culture of Caring | Cardiothoracic Surgery

...-Presbyterian/Weill Cornell physicians who saved Charles’ life: Drs. Leonard Girardi, David Blumenthal...

https://ctsurgery.weillcornell.org/news/donor-spotlight-supporting-culture-caring

Englander Institute creates big data solution | Sandra and Edward Meyer Cancer Center

... who wish to offer appropriate clinical trials to their patients,” said John Leonard, M.D...

https://meyercancer.weill.cornell.edu/news/2016-07-11/englander-institute-creates-big-data-solution

Targeting epigenetic switches may lead to novel therapies for B-cell lymphomas | Sandra and Edward Meyer Cancer Center

... lymphoma Emerging strategies for treating progressive indolent B-Cell NHL Leonard reflects on progress for lymphoma patients ...

https://meyercancer.weill.cornell.edu/news/2015-10-28/targeting-epigenetic-switches-may-lead-novel-therapies-b-cell-lymphomas

3-D organoids allow tests of lymphoma treatments | Sandra and Edward Meyer Cancer Center

... strategies for treating progressive indolent B-Cell NHL Leonard reflects on progress for lymphoma patients ...

https://meyercancer.weill.cornell.edu/news/2015-10-22/3-d-organoids-allow-tests-lymphoma-treatments

Showing results 1301 - 1310 for leonard